Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
Fresenius Medical Care announces publication of a multinational real-world evidence study associating high-volume Hemodiafiltration with lower mortality risk than conventional Hemodialysis (€40.36, 0.00)
Fresenius raises approximately €300M through sale of 7.8M Fresenius Medical Care shares (€46.22, 0.00)
StreetAccount Sector Summary - Healthcare Post-Market
Transcript Intelligence: Fresenius Medical Care Q2 Earnings Guidance
Transcript Intelligence: Fresenius Medical Care Q2 Earnings Themes
Transcript Intelligence: Fresenius Medical Care Q2 Earnings Q&A
StreetAccount Summary - US Pre-market trading update
StreetAccount Sector Summary - Healthcare Pre-Market
Powered by FactSet Research Systems Inc.